• Thiogenesis will hold its annual and special shareholder meeting in San Diego, California on Sept. 8, 2026.
• Shareholders will vote on amending the omnibus equity incentive plan to raise the share reserve to 13,995,931 from 9,099,095.
• The change would restore the plan’s fixed 20% reserve based on current issued and outstanding shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thiogenesis Therapeutics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609030600NEWSFILECNPR____20260903_312667_1) on September 03, 2026, and is solely responsible for the information contained therein.